anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The present invention relates to a hair protection composition containing a medicinal herb extract. According to the present invention, the medicinal herb extract is used in the composition, as is extracted from a medicinal herb mixture comprising: Pleuropterus multiflorus TURCZ., Mori Folium, pine needle, Rehmanniae radix preparata, Mentha arvensis var. piperascens, green tea, Glycyrrhizae Radix, ginger, acanthopanax, and raspberry. Thus, the composition can help keep healthy hair by having functions associated with hair protection, hair loss prevention, dandruff reduction, itchy scalp amelioration, hair growth promotion, and sebum removal. To this end, the composition contains an extract of the medicinal herb mixture composed of Pleuropterus multiflorus TURCZ., Mori Folium, pine needle, Rehmanniae radix preparata, Mentha arvensis var. piperascens, green tea, Glycyrrhizae Radix, and ginger.
The study is planned so that scapular dyskinesia, muscle strength, posture and proprioceptive sense measurements will be taken at 3 different times (before treatment, 8th week and 12th week) for two independent groups (control and experimental groups).Based on the proprioception sense findings in our previous pilot study, the intergroup effect size was predicted to be approximately 0.35 (weak to moderate). Assuming that type I error is 5%, type II is 20%, and the correlation between repeated measurements is 80% (high correlation), the total sample size obtained with the help of G Power 3.1.9.2 software is calculated as 60 people. Individuals are randomly divided into two groups (by blocking method). Groups are matched by stratified random sampling/proportionate distribution by degree of shoulder protraction (acromion level below and above 6.5 cm) and gender.

Study data will be analyzed using the statistical software \[Statistical Package For The Social Sciences Software (SPSS 25.0)\].Frequency and percentage for continuous data, mean, standard deviation, minimum and maximum value for categorical data will be reported. Independent sample t-test to determine the difference according to the groups in continuous variables, analysis of variance in repeated measures to determine the change over time, two-way analysis of variance in repeated measures with repetitions on a single factor to evaluate the group and time change together. Pearson chi-square and Fisher-Freeman-Halton test will be performed model to evaluate the difference according to groups in categorical variables. Bonferonni correction will be used for multiple comparisons, Friedman S and Cochran Q tests will be used to evaluate time-dependent variation, and two-way analysis of variance will be used for repeated measures with repetitions on a single factor to evaluate group and time variation together.The significance level will be accepted as 0.05.
BACKGROUND: Heterotopic gastric mucosa (HGM) can be located in various parts of the gastrointestinal tract. As a rare anomaly in the small intestine, it can become complicated by intussusception, obstruction, gastrointestinal bleeding, and even peritonitis, leading to death.
CASE PRESENTATION: This case report focuses on a 12-year-old Middle Eastern boy who presented with hematochezia and abdominal pain for a couple of days. A tagged Red blood cell (RBC) scan and Technetium scan revealed gastrointestinal bleeding at the lower abdomen, highly suggestive of the diagnosis of Meckel's diverticulum. Subsequently, exploratory laparotomy revealed contiguous and scattered mucosal lesions with multiple polyps of various sizes in the terminal ileum. Meckel's diverticulum was absent, and the patient was treated with resection and primary anastomosis. The resected tissue revealed extensive ectopic gastric mucosa and polypoid tissues. The patient recovered uneventfully and was discharged four days after the surgery. The symptoms did not recur within six months after his surgery.
CONCLUSION: Our case demonstrated that despite the rarity of multiple polypoid gastric heterotopias in the terminal ileum, it should be considered as one of the differential diagnoses of gastrointestinal tract bleeding.
The present invention provides a compound that can be used for targeted drug delivery, imaging a patient, or diagnosing a subject for a clinical condition which is believed to be associated with overexpression and/or upregulation of CXCR4. In particular, the present invention provides a high affinity CXCR4 selective binding ligand peptide conjugate (PC) of the Formula: P-(L-A)n (I) or a pharmaceutically acceptable salt thereof, and a method for using and producing the same. The high affinity CXCR4 selective binding ligand peptide conjugate (PC) of the invention is useful in diagnosing, treating or imaging a patient. In compound of Formula (I), n is an integer from 1 to the sum of (the total number of amino acid resides in P and the total number of side-chain functional group in the amino acid residue of P); each A is independently a diagnostic agent, a therapeutic agent, or an imaging agent; L is a linker or absent; and P is a high affinity CXCR4 selective binding peptidyl ligand. In particular, the invention provides to a targeted drug delivery or imaging a patient or diagnosing a patient for a disease of which overexpression and/or upregulation of CXCR4 is implicated, such as cancers, HIV infection, and immune disorders. Compositions and kits peptide conjugate of Formula I as well as methods for using and producing peptide conjugate of Formula I are disclosed herein.
This study is a randomized, outcome assessor blinded, parallel group, trial to evaluate the effect of non surgical periodontal treatment in the form of scaling and root planing on coronary heart disease patients. 70 clinically defined coronary heart disease (CHD) patients with mild to moderate periodontitis, were allocated into two groups- experimental and control, in a ratio of 1:1. Scaling and root planing was provided as the intervention to the experimental group. To the control group no periodontal intervention in any form was provided. The primary outcome assessed is the changes in C-reactive protein level at baseline and after 1, 3, and 6 months of periodontal intervention. The secondary outcomes assessed are lipid profile, white blood cells (WBC) profile, and blood pressure (systolic and diastolic) at baseline and after 1, 3, and 6 months of periodontal intervention. Periodontal parameters including plaque index (PI), gingival index (GI), bleeding on probing (BOP), periodontal probing depth (PPD), and clinical attachment loss (CAL) is also assessed at baseline and after 6 months. All these parameters were also compared with their corresponding values in the control group.
Enteric gram-negative bacteria-associated peritoneal dialysis (PD) peritonitis is common. These organisms are such as Escherichia coli, Klebsiella and Enterobacter species. Pantoea dispersa belongs to the order Enterobacterales, it has known benefits and a role in agricultural and environmental biotechnology. Pantoea dispersa, although still relatively rare, is being increasingly recognised to cause human infections. We are reporting a case of PD peritonitis caused by Pantoea dispersa in a kidney failure patient on continuous ambulatory peritoneal dialysis (CAPD). His peritonitis was treated well with intraperitoneal antibiotics and the patient can resume his CAPD therapy. The increasing reports of Pantoea dispersa-related human infections warrant concerns, both in immunocompromised and immunocompetent patients.
Excretion

The terminal elimination half-life (t1/2) of dexmedetomidine is approximately 2 hours and clearance is estimated to be approximately 39 L/h. A mass balance study demonstrated that after nine days an average of 95% of the radioactivity, following intravenous administration of radiolabeled dexmedetomidine, was recovered in the urine and 4% in the feces. No unchanged dexmedetomidine was detected in the urine. Approximately 85% of the radioactivity recovered in the urine was excreted within 24 hours after the infusion. Fractionation of the radioactivity excreted in urine demonstrated that products of N-glucuronidation accounted for approximately 34% of the cumulative urinary excretion. In addition, aliphatic hydroxylation of parent drug to form 3-hydroxy-dexmedetomidine, the glucuronide of 3-hydroxy-dexmedetomidine, and 3-carboxylic acid-dexmedetomidine together represented approximately 14% of the dose in urine. N-methylation of dexmedetomidine to form 3-hydroxy N-methyl dexmedetomidine, 3-carboxy N-methyl dexmedetomidine, and N-methyl O-glucuronide dexmedetomidine accounted for approximately 18% of the dose in urine. The N-Methyl metabolite itself was a minor circulating component and was undetected in urine. Approximately 28% of the urinary metabolites have not been identified.
The invention relates to biotechnology, pharmaceuticals, cosmetology and veterinary medicine, and can be used in the preparation of therapeutic, prophylactic, cosmetic and sanitary agents of the spray type for treating air, as well as gels, balms, lotions and liquids for impregnating antiseptic and immune-enhancing wipes, which do not cause side effects. The technical result of the proposed technical solution is that of increasing the overall stability and improving the organoleptic properties of a composition containing essential oils and phytoextracts when diluted, stored or subjected to increases in pressure or to freezing, while also preserving the biological activity of said composition. A basic alcohol-based composition for the preparation of a biologically active agent for treating a person's living environment contains a combination of essential oils and phytoextracts present in a total amount of up to 48%. As a source of essential oils and phytoextracts plants of the Labiatae and Compositae families are used which are rich in terpenoids, flavonoids, carotenoids and anthocyanins. The proposed basic ingredients of the composition are used to produce agents for treating the air in a room using aerosol dispensers. Finished forms of the preparations retain their biological activity when in storage and in use.
PURPOSE:The titled drug, containing various microbial cells of bacteria belonging to acetic acid bacteria as an active constituent, capable of exhibiting the immunological activating action, and effective as an antitumor agent and an immunological activating remedy for bacterial and viral diseases. CONSTITUTION:An immunological activator, containing microbial cells of bacteria belonging to the acetic acid bacteria as an active constituent, directly or formulated into various pharmaceuticals, and orally or parenterally administered. Living microbial cells, dead microbial cells, dried living microbial cells, dried dead microbial cells or ground microbial cells are used as the microbial cells. Acetobacter pastrianus, IFO3223, wtc. may be cited as the bacteria classified as the acetic acid bacteria, and obtained by cultivating the cells aerobically in an ordinary culture medium. The effects of the immunological activator are evaluated by the method of plaque-forming cells (PFC method) for the humoral immunity activating effects and the carbon clearance method for the cellular immunity activating effects, and both immunity activating effects are increased to several times of those of the control.
BACKGROUND: Long COVID-19 is characterized by systemic deterioration of the entire body, leading to significant physical and mental disorders. Exercise training has the potential to improve persistent symptoms and cardiopulmonary functions.
METHOD: This was a single-center, randomized, controlled trial. Twenty-four patients aged 18 to 75 years who had a history of SARS-CoV-2 infection and long COVID symptoms. Patients were randomly allocated in a 1:1 ratio to receive either a 4-week exercise training program or an attention control group. The training group participated in 12 supervised aerobic sessions on a cycling ergometer over 4 weeks. The outcomes were to assess the impact of a 4-week aerobic exercise on the persistent symptoms and cardiopulmonary fitness, the surrogate endpoints of COVID-19 recovery and cardiopulmonary health.
RESULTS: After the 4-week intervention, significant reductions were observed in the total number of symptoms in the training group. Specifically, 67.8% of patients in the training group exhibited reduced or completely resolved symptoms, in comparison to 16.7% in the control group (P = 0.013). After adjusting for gender, significant improvements in the training group were observed for exercise time (Pgroup*time = 0.028), maximum load (Pgroup*time = 0.01), and peak VO2 (Pgroup*time = 0.001), as well as O2 pulse (Pgroup*time = 0.042) and maximum heart rate (Pgroup*time = 0.007). The score of Short Form-12, depression, anxiety, perceived stress, and insomnia did not show significant changes between groups (Pgroup*time > 0.05).
CONCLUSION: A supervised aerobic training program has the potential to alleviate persistent symptoms and improve exercise tolerance in patients with long COVID-19. Further research is necessary to confirm these effects in a large population. This intervention could be easily implemented in non-hospital settings, potentially benefiting a broader range of individuals.
TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT05961462. Registered on July 25, 2023.
BACKGROUND: Laparoscopic appendectomy followed by postoperative intravenous (IV) antibiotics is the standard of care for acute appendicitis and postoperative prevention of intra-abdominal abscesses. The aim of or study was to determine if intraperitoneal irrigation with antibiotics could help prevent intra-abdominal abscess formation after laparoscopic appendectomy for complicated appendicitis in pediatric patients.
METHODS: A retrospective study was conducted on consecutive pediatric patients with acute appendicitis who had appendectomy in our Pediatric Surgery Department between August 2020 and February 2022. We compared two groups with similar age and symptoms. The first group (A) was treated with the normal standard of care, i.e., laparoscopic appendectomy and postoperative IV antibiotic therapy. For the second group (B) intraperitoneal cefazoline irrigation was added at the end of the laparoscopic procedure. Postoperative intra-abdominal abscess was diagnosed with ultrasound examination, performed after clinical suspicion/abnormal blood test results.
RESULTS: One hundred sixty patients (males:females 109:51; median age 10.5 years [range 3-17 years]) who had laparosopic appendectomy for complicated appendicitis were included, 82 in group A and 78 in group B. In the first 7 days after surgery, 18 patients in group and 5 in group B developed an intra-abdominal abscess (p < 0.005). Drains were positioned in 38 patients in group A vs. 9 in group B. One patient in group A had a different complication which was infection of the surgical incision.
CONCLUSIONS: Intraperitoneal cefazoline irrigation at the end of the laparoscopic appendectomy in pediatric patients significantly reduces the formation of intra-abdominal abscesses.
Medical devices, such as non-invasive ventilation masks, save lives in health care settings but can be a cause of tissue injuries due to the pressure and shear loads on skin and soft tissue. These pressure injuries could be painful for the individual and cause a significant economic impact on healthcare providers. In the etiology of device related pressure ulcers, inflammation plays an important role. However, the exact nature and timing of inflammatory biomarker upregulation is still unknown in the early stages of skin damage. This study aimed to explore the inflammatory profile of vulnerable skin sites following non-invasive mask application on a convenience sample of eleven hospital patients. Seventy-one inflammatory proteins were explored from sebum sampled at the skin surface after oronasal mask application. A multivariate analysis to investigate differences between loaded and control site was conducted, with a protein network analysis used to explore interactions in the early inflammation. The study revealed that 21 cytokines and chemokines were important for the separation between loaded and control site. These proteins were associated with remodeling of tissue, vascular wound healing and/or cell death.
The invention belongs to the technical field of articles for daily use and discloses an oral cleaning wet tissue. The oral cleaning wet tissue comprises a biodegradable base material and impregnation liquid. The biodegradable base material is made by weaving of cellulosic fibers and chitin fibers. The impregnation liquid is prepared from, by weight, 1-3 parts of glucolactone, 1-3 parts of maltose fatty acid ester, 10-20 parts of xylitol, 5-10 parts of mint leaves and 100 parts of purified water, wherein citric acid and sodium citrate adjust pH to 3.5-5.5. The oral cleaning wet tissue is effective in cleaning of bacteria and residues in oral cavity and can be used by infants due to safety and nontoxicity of components. By adoption of a biodegradable antibacterial wet tissue as the base material, the problem of bacterium resistance of the wet tissue is effectively solved while pressure caused by hard degradability of the wet tissue to the environment is relieved.
The impact of aortic valve stenosis (AS) extends beyond the vicinity of the narrowed leaflets into the left ventricle (LV) and into the systemic vasculature because of highly unpredictable valve behavior and complex blood flow in the ascending aorta that can be attributed to the strong interaction between the narrowed cusps and the ejected blood. These effects can become exacerbated during exercise and may have implications for disease progression, accurate diagnosis, and timing of intervention. In this 3-D patient-specific study, we employ strongly coupled fluid-structure interaction (FSI) modeling to perform a comprehensive biomechanical evaluation of systolic ejection dynamics in a stenosed aortic valve (AV) during increasing LV contraction. Our model predictions reveal that the heterogeneous ∆P vs. Q relationship that was observed in our previous clinical study can be attributed to a non-linear increase (by ~ 1.5-fold) in aortic valve area as LV heart rate increases from 70 to 115 bpm. Furthermore, our results show that even for a moderately stenotic valve, increased LV contraction during exercise can lead to high-velocity flow turbulence (Re = 11,700) in the aorta similar to that encountered with a severely stenotic valve (Re ~ 10,000), with concomitant greater viscous loss (~3-fold increase) and elevated wall stress in the ascending aorta. Our FSI predictions also reveal that individual valve cusps undergo distinct and highly non-linear increases (>100%) in stress during exercise, potentially contributing to progressive calcification. Such quantitative biomechanical evaluations from realistic FSI workflows provide insights into disease progression and can be integrated with current stress testing for AS patients to comprehensively predict hemodynamics and valve function under both baseline and exercise conditions.
BACKGROUND: Chronic health conditions impact worker outcomes but are challenging to measure using administrative workers' compensation (WC) data. The Functional Comorbidity Index (FCI) was developed to predict functional outcomes in community-based adult populations, but has not been validated for WC settings. We assessed a WC-based FCI (additive index of 18 conditions) for identifying chronic conditions and predicting work outcomes.
METHODS: WC data were linked to a prospective survey in Ohio (N = 512) and Washington (N = 2,839). Workers were interviewed 6 weeks and 6 months after work-related injury. Observed prevalence and concordance were calculated; survey data provided the reference standard for WC data. Predictive validity and utility for control of confounding were assessed using 6-month work-related outcomes.
RESULTS: The WC-based FCI had high specificity but low sensitivity and was weakly associated with work-related outcomes. The survey-based FCI suggested more comorbidity in the Ohio sample (Ohio mean = 1.38; Washington mean = 1.14), whereas the WC-based FCI suggested more comorbidity in the Washington sample (Ohio mean = 0.10; Washington mean = 0.33). In the confounding assessment, adding the survey-based FCI to the base model moved the state effect estimates slightly toward null (<1% change). However, substituting the WC-based FCI moved the estimate away from null (8.95% change).
CONCLUSIONS: The WC-based FCI may be useful for identifying specific subsets of workers with chronic conditions, but less useful for chronic condition prevalence. Using the WC-based FCI cross-state appeared to introduce substantial confounding. We strongly advise caution-including state-specific analyses with a reliable reference standard-before using a WC-based FCI in studies involving multiple states.
Disclosed herein are systems, methods, and devices for classifying ophthalmic images according to disease type, state, and stage. The disclosed invention details systems, methods, and devices to perform the aforementioned classification based on weighted-linkage of an ensemble of machine learning models. In some parts, each model is trained on a training data set and tested on a test dataset. In other parts, the models are ranked based on classification performance, and model weights are assigned based on model rank. To classify an ophthalmic image, that image is presented to each model of the ensemble for classification, yielding a probabilistic classification score—of each model. Using the model weights, a weighted-average of the individual model-generated probabilistic scores is computed and used for the classification.
The present application pertains to the medical sector and comprises a biodegradable gestrinone implant in a polymer matrix. The implant is inserted subdermally and provides continuous release of the active substance for an extended period of time. This release is intended to ensure a drug serum level that is effective, constant and prolonged for the treatment of endometriosis. The polymer matrix can be formed by one polymer or a blend of polymers. To provide a more constant and uniform release of the active substance, the implants have geometric shapes that retain their surface area over time. The implant can have a polymer lining membrane and can last for 4.5 to 6 months, this being the recommended time between insertion of the implants.